Current Cancer Drug Targets
Title: Erratum
Volume: 3 Issue: 2
Export Options
About this article
Cite this article as:
Erratum, Current Cancer Drug Targets 2003; 3 (2) . https://dx.doi.org/10.2174/1568009033482029
DOI https://dx.doi.org/10.2174/1568009033482029 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer
Current Genomics Heterogeneous Nuclear Ribonucleoprotein A2/B1 as a Target Antigen in Han Chinese for BD Patients
Protein & Peptide Letters Biomarker Discovery in Clinical Proteomics: Strategies for Exposing Low Abundant Proteins
Current Proteomics Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke
Current Drug Targets Stereotactic Body Radiation Therapy in Head and Neck Squamous Cell Carcinoma: Science or Art?
Current Cancer Therapy Reviews Targeting Intracellular Targets
Current Drug Delivery Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Current Genomics Progress in Chemo- and Regioselective Transformations of Symmetrical Cephalostatin Analogues
Letters in Organic Chemistry Cystathionine β-synthase Induces Multidrug Resistance and Metastasis in Hepatocellular Carcinoma
Current Molecular Medicine Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families
Endocrine, Metabolic & Immune Disorders - Drug Targets Angiotensin-Converting Enzymes (ACE and ACE2) as Potential Targets for Malignant Epithelial Neoplasia: Review and Bioinformatics Analyses Focused in Oral Squamous Cell Carcinoma
Protein & Peptide Letters Multiple Hormonal Dysregulation as Determinant of Low Physical Performance and Mobility in Older Persons
Current Pharmaceutical Design Using Cheminformatics for the Identification of Biological Functions of Small Molecules in Metabolic Pathway
Current Topics in Medicinal Chemistry Functional Properties of Kefiran in the Medical Field and Food Industry
Current Pharmaceutical Biotechnology Hepatocytes as Cytotoxic Effector Cells
Current Immunology Reviews (Discontinued) Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Current Genomics Safety and Utilization of Blood Components as Therapeutic Delivery Systems
Current Pharmaceutical Biotechnology The Expression, Function and Targeting of Haem Oxygenase-1 in Cancer
Current Cancer Drug Targets